{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T23:49:21Z","timestamp":1773272961649,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2012,2,4]],"date-time":"2012-02-04T00:00:00Z","timestamp":1328313600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1007\/s12032-012-0176-1","type":"journal-article","created":{"date-parts":[[2012,2,3]],"date-time":"2012-02-03T12:29:59Z","timestamp":1328272199000},"page":"2364-2371","source":"Crossref","is-referenced-by-count":24,"title":["Prognostic significance of T cell subsets in peripheral blood of B cell non-Hodgkin\u2019s lymphoma patients"],"prefix":"10.1007","volume":"29","author":[{"given":"Mehdi","family":"Dehghani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shokouh","family":"Sharifpour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Amirghofran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamid Reza","family":"Zare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,2,4]]},"reference":[{"key":"176_CR1","unstructured":"Lichtman MA, Beutler E, Kipps TJ, et al. Williams text book of hematology.7th ed. New York, NY: Mc Graw Hill; 2006."},{"key":"176_CR2","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.addr.2006.05.006","volume":"58","author":"GJ Betts","year":"2006","unstructured":"Betts GJ, Clarke SL, Richards HE, et al. Regulating the immune response to tumors. Adv Drug Deliv Rev. 2006;58:948\u201361.","journal-title":"Adv Drug Deliv Rev"},{"key":"176_CR3","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1158\/1055-9965.EPI-06-1070","volume":"16","author":"AE Grulich","year":"2007","unstructured":"Grulich AE, Vajdic CM, Cozen W. Altered immunity as a risk factor for non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev. 2007;16:405\u20138.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"176_CR4","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1699-0463.1997.tb00592.x","volume":"105","author":"M Vasei","year":"1997","unstructured":"Vasei M, Kumar PV, Malekhosseini SA, Amirghofran Z. Primary T-cell lymphoma of the breast with lymphoepithelial lesion. A case report. APMIS. 1997;105:445\u20138.","journal-title":"APMIS"},{"key":"176_CR5","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1200\/JCO.2010.33.3252","volume":"29","author":"H Nogai","year":"2011","unstructured":"Nogai H, D\u00f6rken B, Lenz G. Pathogenesis of Non-Hodgkin\u2019s lymphoma. J Clin Oncol. 2011;29:1803\u201311.","journal-title":"J Clin Oncol"},{"key":"176_CR6","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/IGC.0b013e3182131f36","volume":"21","author":"JJ Sznurkowski","year":"2011","unstructured":"Sznurkowski JJ, Zawrocki A, Emerich J, et al. Prognostic significance of CD4+ and CD8+ T cell infiltration within cancer cell nests in vulvar squamous cell carcinoma. Int J Gynecol Cancer. 2011;21:717\u201321.","journal-title":"Int J Gynecol Cancer"},{"key":"176_CR7","doi-asserted-by":"crossref","first-page":"7233","DOI":"10.3748\/wjg.v12.i45.7233","volume":"12","author":"M Waldner","year":"2006","unstructured":"Waldner M, Schimanski CC, Neurath MF. Colon cancer and the immune system: the role of tumor invading T cells. World J Gastroenterol. 2006;12:7233\u20138.","journal-title":"World J Gastroenterol"},{"key":"176_CR8","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1200\/JCO.2001.19.3.720","volume":"19","author":"SM Ansell","year":"2001","unstructured":"Ansell SM, Stenson M, Habermann TM, et al. CD4+ T-cell immune response to large B-cell non-Hodgkin\u2019s lymphoma predicts patient outcome. J Clin Oncol. 2001;19:720\u20136.","journal-title":"J Clin Oncol"},{"key":"176_CR9","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1001\/archoto.2010.211","volume":"136","author":"D Wansom","year":"2010","unstructured":"Wansom D, Light E, Worden F, et al. Correlation of cellular immunity with human papillomavirus status and outcome in patients with advanced oropharyngeal cancer. Arch Otolaryngol Head Neck Surg. 2010;136:1267\u201373.","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"176_CR10","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/00008390-200412000-00009","volume":"14","author":"MM Hernberg","year":"2004","unstructured":"Hernberg MM, Hahka-Kemppinen MH, Pyrhonen SO. The prognostic role of CD4+ and CD8+ lymphocytes during chemoimmunotherapy in metastatic melanoma. Melanoma Res. 2004;14:493\u2013500.","journal-title":"Melanoma Res"},{"key":"176_CR11","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/cyto.10003","volume":"50","author":"W Gorczyca","year":"2002","unstructured":"Gorczyca W, Weisberger J, Liu Z, et al. An approach to diagnosis of T-cell lymphoproliferative disorders by flow cytometry. Cytometry. 2002;50:177\u201390.","journal-title":"Cytometry"},{"key":"176_CR12","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1182\/blood.V74.6.2121.2121","volume":"74","author":"LJ Medeiros","year":"1989","unstructured":"Medeiros LJ, Harmon DC, Linggood RM, et al. Immunohistologic features predict clinical behavior of orbital and conjunctival lymphoid infiltrates. Blood. 1989;74:2121\u20139.","journal-title":"Blood"},{"key":"176_CR13","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1200\/JCO.1990.8.6.986","volume":"8","author":"DJ Slymen","year":"1990","unstructured":"Slymen DJ, Miller TP, Lippman SM, et al. Immunobiologic factors predictive of clinical outcome in diffuse large-cell lymphoma. J Clin Oncol. 1990;8:986\u201393.","journal-title":"J Clin Oncol"},{"key":"176_CR14","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0065-230X(10)07003-X","volume":"107","author":"D Mougiakakos","year":"2010","unstructured":"Mougiakakos D, Choudhury A, Lladser A, et al. Regulatory Tcells in cancer. Adv Cancer Res. 2010;107:57\u2013117.","journal-title":"Adv Cancer Res"},{"key":"176_CR15","first-page":"3334","volume":"123","author":"LL Feng","year":"2010","unstructured":"Feng LL, Wang X. Targeting Foxp3+ regulatory T cells-related immunosuppression for cancer immunotherapy. Chin Med J (Engl). 2010;123:3334\u201342.","journal-title":"Chin Med J (Engl)"},{"key":"176_CR16","doi-asserted-by":"crossref","first-page":"10145","DOI":"10.1158\/0008-5472.CAN-06-1822","volume":"66","author":"ZZ Yang","year":"2006","unstructured":"Yang ZZ, Novak AJ, Ziesmer SC, et al. Attenuation of CD8+ T-cell function by CD4+CD25+ regulatory T cells in B-cell non-Hodgkin\u2019s lymphoma. Cancer Res. 2006;66:10145\u201352.","journal-title":"Cancer Res"},{"key":"176_CR17","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.2337\/diabetes.54.5.1407","volume":"54","author":"TM Brusko","year":"2005","unstructured":"Brusko TM, Wasserfall CH, Clare-Salzler MJ, et al. Functional defects and the influence of age on the frequency of CD4+CD25+ T-cells in type 1 diabetes. Diabetes. 2005;54:1407\u201314.","journal-title":"Diabetes"},{"key":"176_CR18","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1200\/JCO.2009.26.2493","volume":"28","author":"M Ziepert","year":"2010","unstructured":"Ziepert M, Hasenclever D, Kuhnt E, et al. Standard International prognostic index remains a valid predictor of outcome for patients with aggressive CD20+ B-cell lymphoma in the rituximab era. J Clin Oncol. 2010;28:2373\u201380.","journal-title":"J Clin Oncol"},{"key":"176_CR19","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kapplan","year":"1958","unstructured":"Kapplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457\u201381.","journal-title":"J Am Stat Assoc"},{"key":"176_CR20","first-page":"80","volume":"4","author":"SH Shahghasempour","year":"2001","unstructured":"Shahghasempour SH, Gerami M, Entezami Z. Enumeration of peripheral blood lymphocyte subsets in a healthy Iranian population. Arch Iran Med. 2001;4:80\u20133.","journal-title":"Arch Iran Med"},{"key":"176_CR21","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1182\/blood-2006-02-002774","volume":"108","author":"M Beyer","year":"2006","unstructured":"Beyer M, Schultze JL. Regulatory T cells in cancer. Blood. 2006;108:804\u20138.","journal-title":"Blood"},{"key":"176_CR22","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s00277-010-0945-x","volume":"89","author":"A Chatzitolios","year":"2010","unstructured":"Chatzitolios A, Venizelos I, Tripsiannis G, et al. Prognostic significance of CD95, P53, and BCL2 expression in extranodal non-Hodgkin\u2019s lymphoma. Ann Hematol. 2010;89:889\u201396.","journal-title":"Ann Hematol"},{"key":"176_CR23","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.imlet.2004.10.005","volume":"97","author":"L V\u00e1r\u00f3czy","year":"2005","unstructured":"V\u00e1r\u00f3czy L, Gergely L, Milt\u00e9nyi Z, et al. Can CD3+\/HLA-DR+ activated T cells predict the prognosis of non-Hodgkin\u2019s lymphoma patients? Immunol Lett. 2005;97:155\u20137.","journal-title":"Immunol Lett"},{"key":"176_CR24","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1046\/j.1365-2141.2001.02649.x","volume":"112","author":"Y Xu","year":"2001","unstructured":"Xu Y, Kroft SH, McKenna RW, et al. Prognostic significance of tumour-infiltrating T lymphocytes and T-cell subsets in de novo diffuse large B-cell lymphoma: a multiparameter flow cytometry study. Br J Haematol. 2001;112:945\u20139.","journal-title":"Br J Haematol"},{"key":"176_CR25","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1007\/s11596-006-0516-5","volume":"26","author":"L Liu","year":"2006","unstructured":"Liu L, Yao J, Ding Q, et al. CD4+CD25 high regulatory cells in peripheral blood of NSCLC patients. J Huazhong Univ Sci Technol Med Sci. 2006;26:548\u201351.","journal-title":"J Huazhong Univ Sci Technol Med Sci"},{"key":"176_CR26","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.exphem.2007.01.030","volume":"35","author":"NA Marshall","year":"2007","unstructured":"Marshall NA, Culligan DJ, Tighe J, et al. The relationships between Epstein-Barr virus latent membrane protein 1 and regulatory T cells in Hodgkin\u2019s lymphoma. Exp Hematol. 2007;35:596\u2013604.","journal-title":"Exp Hematol"},{"key":"176_CR27","doi-asserted-by":"crossref","first-page":"5350","DOI":"10.1200\/JCO.2006.06.4766","volume":"24","author":"T Alvaro","year":"2006","unstructured":"Alvaro T, Lejeune M, Salvad\u00f3 MT, et al. Immunohistochemical patterns of reactive microenvironment are associated with clinicobiologic behavior in follicular lymphoma patients. J Clin Oncol. 2006;24:5350\u20137.","journal-title":"J Clin Oncol"},{"key":"176_CR28","first-page":"597","volume":"23","author":"X Shi","year":"2004","unstructured":"Shi X, Zhang XS, Liu DG, et al. CD4+CD25+ T regulatory cells in peripheral blood of B-NHL patients with or without chemotherapy. Ai Zheng. 2004;23:597\u2013601.","journal-title":"Ai Zheng"},{"key":"176_CR29","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3324\/haematol.11702","volume":"93","author":"A Tzankov","year":"2008","unstructured":"Tzankov A, Meier C, Hirschmann P, et al. Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin\u2019s lymphoma. Haematologica. 2008;93:193\u2013200.","journal-title":"Haematologica"},{"key":"176_CR30","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-2559.2010.03706.x","volume":"58","author":"SE Coupland","year":"2011","unstructured":"Coupland SE. The challenge of the microenvironment in B-cell lymphomas. Histopathology. 2011;58:69\u201380.","journal-title":"Histopathology"},{"key":"176_CR31","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1182\/blood-2006-04-018218","volume":"108","author":"E Montserrat","year":"2006","unstructured":"Montserrat E, Campo E, Banham AH, et al. High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma. Blood. 2006;108:2957\u201364.","journal-title":"Blood"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-012-0176-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-012-0176-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-012-0176-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T17:47:30Z","timestamp":1593625650000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-012-0176-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,4]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["176"],"URL":"https:\/\/doi.org\/10.1007\/s12032-012-0176-1","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,4]]}}}